China Puts the Brakes on Imports of Pfizer’s Diflucan

| + More Articles
  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn


China’s drug watchdog has suspended imports of one medication from the pharmaceutical giant Pfizer, saying that the company was late in filing it’s application; the drug in question is an anti-fungal drug used in the treatment of AIDS, called Diflucan. The suspension is just one of several similar recent incidents indicative of China’s increasing scrutiny of the pharmaceutical industry, says the Wall Street Journal.

Tuesday the Chinese Food and Drug Administration said that it recently inspected a Pfizer factory in France and found that the pharmaceutical giant failed to submit a supplementary application for the AIDS drug, Diflucan, on time.

Pfizer responded in a statement on its Chinese-language website; the company said it is complying with the Chinese FDA and taking necessary steps to resolve the problem, according to the Wall Street Journal. Pfizer also said that the reason for the suspension had nothing to do with issues of the drug’s safety or quality, but was merely an issue of proper documentation according to Chinese law.

More Articles About:

To contact the reporter on this story: To contact the editor responsible for this story:

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business